APO Research
Talk to an analyst

APO RESEARCH · REPORT

Porcine Circovirus Diseases Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Porcine Circovirus Diseases Vaccine Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchPorcine Circovirus Diseases Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Circovirus Diseases Vaccine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Porcine Circovirus Diseases Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Circovirus Diseases Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Circovirus Diseases Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Porcine Circovirus Diseases Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Porcine Circovirus Diseases Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Porcine Circovirus Diseases Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Porcine Circovirus Diseases Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Porcine Circovirus Diseases Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Porcine Circovirus Diseases Vaccine market include Zoetis, Yebio Bioengineering, Pulike Biological Engineering, Nannong Hi-Tech, Merck, Jinyu Bio-technology, Jinhe Biotechnology, Hile Bio-Technology and Ceva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Porcine Circovirus Diseases Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Porcine Circovirus Diseases Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Porcine Circovirus Diseases Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Porcine Circovirus Diseases Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Porcine Circovirus Diseases Vaccine Segment by Company

Zoetis

Yebio Bioengineering

Pulike Biological Engineering

Nannong Hi-Tech

Merck

Jinyu Bio-technology

Jinhe Biotechnology

Hile Bio-Technology

Ceva

Boehringer Ingelheim

Porcine Circovirus Diseases Vaccine Segment by Type

Inactivated Vaccine

Genetically Engineered Vaccine

Porcine Circovirus Diseases Vaccine Segment by Application

Piglet

Fertile Sow

Porcine Circovirus Diseases Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Porcine Circovirus Diseases Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Porcine Circovirus Diseases Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Porcine Circovirus Diseases Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Porcine Circovirus Diseases Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Circovirus Diseases Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Circovirus Diseases Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Circovirus Diseases Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Porcine Circovirus Diseases Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Porcine Circovirus Diseases Vaccine industry.

Chapter 3: Detailed analysis of Porcine Circovirus Diseases Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Porcine Circovirus Diseases Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Porcine Circovirus Diseases Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Porcine Circovirus Diseases Vaccine Industry Trends Table 2. Porcine Circovirus Diseases Vaccine Industry Drivers Table 3. Porcine Circovirus Diseases Vaccine Industry Opportunities and Challenges Table 4. Porcine Circovirus Diseases Vaccine Industry Restraints Table 5. Global Porcine Circovirus Diseases Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Porcine Circovirus Diseases Vaccine Revenue Share by Company (2021-2026) Table 7. Global Porcine Circovirus Diseases Vaccine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Porcine Circovirus Diseases Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Porcine Circovirus Diseases Vaccine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Porcine Circovirus Diseases Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Porcine Circovirus Diseases Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Porcine Circovirus Diseases Vaccine Company, Product Type & Application Table 13. Global Porcine Circovirus Diseases Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Porcine Circovirus Diseases Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Inactivated Vaccine Table 18. Significant Companies of Genetically Engineered Vaccine Table 19. Global Porcine Circovirus Diseases Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Porcine Circovirus Diseases Vaccine Sales Volume by Type (2021-2026) & (k units) Table 21. Global Porcine Circovirus Diseases Vaccine Sales Volume by Type (2027-2032) & (k units) Table 22. Global Porcine Circovirus Diseases Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Porcine Circovirus Diseases Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Porcine Circovirus Diseases Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Porcine Circovirus Diseases Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Porcine Circovirus Diseases Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Porcine Circovirus Diseases Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Porcine Circovirus Diseases Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Piglet Table 30. Significant Companies of Fertile Sow Table 31. Global Porcine Circovirus Diseases Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Porcine Circovirus Diseases Vaccine Sales Volume by Application (2021-2026) & (k units) Table 33. Global Porcine Circovirus Diseases Vaccine Sales Volume by Application (2027-2032) & (k units) Table 34. Global Porcine Circovirus Diseases Vaccine Sales Volume Share by Application (2021-2026) Table 35. Global Porcine Circovirus Diseases Vaccine Sales Volume Share by Application (2027-2032) Table 36. Global Porcine Circovirus Diseases Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Porcine Circovirus Diseases Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Porcine Circovirus Diseases Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Porcine Circovirus Diseases Vaccine Sales Value Share by Application (2021-2026) Table 40. Global Porcine Circovirus Diseases Vaccine Sales Value Share by Application (2027-2032) Table 41. Global Porcine Circovirus Diseases Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Porcine Circovirus Diseases Vaccine Sales by Region (2021-2026) & (k units) Table 43. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Porcine Circovirus Diseases Vaccine Sales by Region (2027-2032) & (k units) Table 45. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Region (2027-2032) Table 46. Global Porcine Circovirus Diseases Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Porcine Circovirus Diseases Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Porcine Circovirus Diseases Vaccine Sales Value Share by Region (2021-2026) Table 49. Global Porcine Circovirus Diseases Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Porcine Circovirus Diseases Vaccine Sales Value Share by Region (2027-2032) Table 51. Global Porcine Circovirus Diseases Vaccine Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Porcine Circovirus Diseases Vaccine Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Porcine Circovirus Diseases Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Porcine Circovirus Diseases Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026) & (k units) Table 56. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Country (2021-2026) Table 57. Global Porcine Circovirus Diseases Vaccine Sales by Country (2027-2032) & (k units) Table 58. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Country (2027-2032) Table 59. Global Porcine Circovirus Diseases Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Porcine Circovirus Diseases Vaccine Sales Value Market Share by Country (2021-2026) Table 61. Global Porcine Circovirus Diseases Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Porcine Circovirus Diseases Vaccine Sales Value Market Share by Country (2027-2032) Table 63. Zoetis Company Information Table 64. Zoetis Business Overview Table 65. Zoetis Porcine Circovirus Diseases Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Zoetis Porcine Circovirus Diseases Vaccine Product Portfolio Table 67. Zoetis Recent Development Table 68. Yebio Bioengineering Company Information Table 69. Yebio Bioengineering Business Overview Table 70. Yebio Bioengineering Porcine Circovirus Diseases Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Yebio Bioengineering Porcine Circovirus Diseases Vaccine Product Portfolio Table 72. Yebio Bioengineering Recent Development Table 73. Pulike Biological Engineering Company Information Table 74. Pulike Biological Engineering Business Overview Table 75. Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Product Portfolio Table 77. Pulike Biological Engineering Recent Development Table 78. Nannong Hi-Tech Company Information Table 79. Nannong Hi-Tech Business Overview Table 80. Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Product Portfolio Table 82. Nannong Hi-Tech Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Porcine Circovirus Diseases Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Merck Porcine Circovirus Diseases Vaccine Product Portfolio Table 87. Merck Recent Development Table 88. Jinyu Bio-technology Company Information Table 89. Jinyu Bio-technology Business Overview Table 90. Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Product Portfolio Table 92. Jinyu Bio-technology Recent Development Table 93. Jinhe Biotechnology Company Information Table 94. Jinhe Biotechnology Business Overview Table 95. Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Product Portfolio Table 97. Jinhe Biotechnology Recent Development Table 98. Hile Bio-Technology Company Information Table 99. Hile Bio-Technology Business Overview Table 100. Hile Bio-Technology Porcine Circovirus Diseases Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Hile Bio-Technology Porcine Circovirus Diseases Vaccine Product Portfolio Table 102. Hile Bio-Technology Recent Development Table 103. Ceva Company Information Table 104. Ceva Business Overview Table 105. Ceva Porcine Circovirus Diseases Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Ceva Porcine Circovirus Diseases Vaccine Product Portfolio Table 107. Ceva Recent Development Table 108. Boehringer Ingelheim Company Information Table 109. Boehringer Ingelheim Business Overview Table 110. Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Product Portfolio Table 112. Boehringer Ingelheim Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Porcine Circovirus Diseases Vaccine Distributors List Table 116. Porcine Circovirus Diseases Vaccine Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Porcine Circovirus Diseases Vaccine Product Image Figure 2. Global Porcine Circovirus Diseases Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Circovirus Diseases Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Porcine Circovirus Diseases Vaccine Sales (2021-2032) & (k units) Figure 5. Global Porcine Circovirus Diseases Vaccine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Porcine Circovirus Diseases Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Inactivated Vaccine Image Figure 10. Genetically Engineered Vaccine Image Figure 11. Global Porcine Circovirus Diseases Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Porcine Circovirus Diseases Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Porcine Circovirus Diseases Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Porcine Circovirus Diseases Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Porcine Circovirus Diseases Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Porcine Circovirus Diseases Vaccine Sales Value Share by Type (2021-2032) Figure 17. Piglet Image Figure 18. Fertile Sow Image Figure 19. Global Porcine Circovirus Diseases Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Porcine Circovirus Diseases Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Porcine Circovirus Diseases Vaccine Sales Volume Share by Application (2021-2032) Figure 22. Global Porcine Circovirus Diseases Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Porcine Circovirus Diseases Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Porcine Circovirus Diseases Vaccine Sales Value Share by Application (2021-2032) Figure 25. Global Porcine Circovirus Diseases Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Porcine Circovirus Diseases Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Porcine Circovirus Diseases Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Porcine Circovirus Diseases Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Porcine Circovirus Diseases Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Porcine Circovirus Diseases Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Porcine Circovirus Diseases Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Porcine Circovirus Diseases Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Porcine Circovirus Diseases Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Porcine Circovirus Diseases Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Porcine Circovirus Diseases Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Porcine Circovirus Diseases Vaccine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Porcine Circovirus Diseases Vaccine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Genetically Engineered Vaccine
Applications
  • Piglet
  • Fertile Sow
Companies covered
  • Zoetis
  • Yebio Bioengineering
  • Pulike Biological Engineering
  • Nannong Hi-Tech
  • Merck
  • Jinyu Bio-technology
  • Jinhe Biotechnology
  • Hile Bio-Technology
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Porcine Circovirus Diseases Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Porcine Circovirus Diseases Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Porcine Circovirus Diseases Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Porcine Circovirus Diseases Vaccine Market Dynamics
  1. 2.1 Porcine Circovirus Diseases Vaccine Industry Trends
  2. 2.2 Porcine Circovirus Diseases Vaccine Industry Drivers
  3. 2.3 Porcine Circovirus Diseases Vaccine Industry Opportunities and Challenges
  4. 2.4 Porcine Circovirus Diseases Vaccine Industry Restraints
3 Porcine Circovirus Diseases Vaccine Market by Company
  1. 3.1 Global Porcine Circovirus Diseases Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Porcine Circovirus Diseases Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Porcine Circovirus Diseases Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Porcine Circovirus Diseases Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Porcine Circovirus Diseases Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Porcine Circovirus Diseases Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Porcine Circovirus Diseases Vaccine Company Product Type and Application
  8. 3.8 Global Porcine Circovirus Diseases Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Porcine Circovirus Diseases Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Porcine Circovirus Diseases Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Porcine Circovirus Diseases Vaccine Market by Type
  1. 4.1 Porcine Circovirus Diseases Vaccine Type Introduction
  2. 4.1.1 Inactivated Vaccine
  3. 4.1.2 Genetically Engineered Vaccine
  4. 4.2 Global Porcine Circovirus Diseases Vaccine Sales Volume by Type
  5. 4.2.1 Global Porcine Circovirus Diseases Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Porcine Circovirus Diseases Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Porcine Circovirus Diseases Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Porcine Circovirus Diseases Vaccine Sales Value by Type
  9. 4.3.1 Global Porcine Circovirus Diseases Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Porcine Circovirus Diseases Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Porcine Circovirus Diseases Vaccine Sales Value Share by Type (2021-2032)
5 Porcine Circovirus Diseases Vaccine Market by Application
  1. 5.1 Porcine Circovirus Diseases Vaccine Application Introduction
  2. 5.1.1 Piglet
  3. 5.1.2 Fertile Sow
  4. 5.2 Global Porcine Circovirus Diseases Vaccine Sales Volume by Application
  5. 5.2.1 Global Porcine Circovirus Diseases Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Porcine Circovirus Diseases Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Porcine Circovirus Diseases Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Porcine Circovirus Diseases Vaccine Sales Value by Application
  9. 5.3.1 Global Porcine Circovirus Diseases Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Porcine Circovirus Diseases Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Porcine Circovirus Diseases Vaccine Sales Value Share by Application (2021-2032)
6 Porcine Circovirus Diseases Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Porcine Circovirus Diseases Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Porcine Circovirus Diseases Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Porcine Circovirus Diseases Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Porcine Circovirus Diseases Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Porcine Circovirus Diseases Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Porcine Circovirus Diseases Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Porcine Circovirus Diseases Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Porcine Circovirus Diseases Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Porcine Circovirus Diseases Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Porcine Circovirus Diseases Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Porcine Circovirus Diseases Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Porcine Circovirus Diseases Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Porcine Circovirus Diseases Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Porcine Circovirus Diseases Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Porcine Circovirus Diseases Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Porcine Circovirus Diseases Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Porcine Circovirus Diseases Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Value Share by Country, 2025 VS 2032
7 Porcine Circovirus Diseases Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Porcine Circovirus Diseases Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Porcine Circovirus Diseases Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Porcine Circovirus Diseases Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Porcine Circovirus Diseases Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Porcine Circovirus Diseases Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Porcine Circovirus Diseases Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Porcine Circovirus Diseases Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Porcine Circovirus Diseases Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Porcine Circovirus Diseases Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Porcine Circovirus Diseases Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Porcine Circovirus Diseases Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Porcine Circovirus Diseases Vaccine Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Yebio Bioengineering
  8. 8.2.1 Yebio Bioengineering Company Information
  9. 8.2.2 Yebio Bioengineering Business Overview
  10. 8.2.3 Yebio Bioengineering Porcine Circovirus Diseases Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yebio Bioengineering Porcine Circovirus Diseases Vaccine Product Portfolio
  12. 8.2.5 Yebio Bioengineering Recent Developments
  13. 8.3 Pulike Biological Engineering
  14. 8.3.1 Pulike Biological Engineering Company Information
  15. 8.3.2 Pulike Biological Engineering Business Overview
  16. 8.3.3 Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Product Portfolio
  18. 8.3.5 Pulike Biological Engineering Recent Developments
  19. 8.4 Nannong Hi-Tech
  20. 8.4.1 Nannong Hi-Tech Company Information
  21. 8.4.2 Nannong Hi-Tech Business Overview
  22. 8.4.3 Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Product Portfolio
  24. 8.4.5 Nannong Hi-Tech Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Porcine Circovirus Diseases Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merck Porcine Circovirus Diseases Vaccine Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Jinyu Bio-technology
  32. 8.6.1 Jinyu Bio-technology Company Information
  33. 8.6.2 Jinyu Bio-technology Business Overview
  34. 8.6.3 Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Product Portfolio
  36. 8.6.5 Jinyu Bio-technology Recent Developments
  37. 8.7 Jinhe Biotechnology
  38. 8.7.1 Jinhe Biotechnology Company Information
  39. 8.7.2 Jinhe Biotechnology Business Overview
  40. 8.7.3 Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Product Portfolio
  42. 8.7.5 Jinhe Biotechnology Recent Developments
  43. 8.8 Hile Bio-Technology
  44. 8.8.1 Hile Bio-Technology Company Information
  45. 8.8.2 Hile Bio-Technology Business Overview
  46. 8.8.3 Hile Bio-Technology Porcine Circovirus Diseases Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hile Bio-Technology Porcine Circovirus Diseases Vaccine Product Portfolio
  48. 8.8.5 Hile Bio-Technology Recent Developments
  49. 8.9 Ceva
  50. 8.9.1 Ceva Company Information
  51. 8.9.2 Ceva Business Overview
  52. 8.9.3 Ceva Porcine Circovirus Diseases Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Ceva Porcine Circovirus Diseases Vaccine Product Portfolio
  54. 8.9.5 Ceva Recent Developments
  55. 8.10 Boehringer Ingelheim
  56. 8.10.1 Boehringer Ingelheim Company Information
  57. 8.10.2 Boehringer Ingelheim Business Overview
  58. 8.10.3 Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Product Portfolio
  60. 8.10.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Porcine Circovirus Diseases Vaccine Value Chain Analysis
  2. 9.1.1 Porcine Circovirus Diseases Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Porcine Circovirus Diseases Vaccine Sales Mode & Process
  6. 9.2 Porcine Circovirus Diseases Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Porcine Circovirus Diseases Vaccine Distributors
  9. 9.2.3 Porcine Circovirus Diseases Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst